142 related articles for article (PubMed ID: 26100315)
1. Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.
Janssens K; Slaets H; Hellings N
Ann N Y Acad Sci; 2015 Sep; 1351():52-60. PubMed ID: 26100315
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Janssens K; Van den Haute C; Baekelandt V; Lucas S; van Horssen J; Somers V; Van Wijmeersch B; Stinissen P; Hendriks JJ; Slaets H; Hellings N
Brain Behav Immun; 2015 Mar; 45():180-8. PubMed ID: 25514345
[TBL] [Abstract][Full Text] [Related]
3. IL-6: regulator of Treg/Th17 balance.
Kimura A; Kishimoto T
Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
[TBL] [Abstract][Full Text] [Related]
4. Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines.
West NR
Front Immunol; 2019; 10():1093. PubMed ID: 31156640
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?
Zweiman B; Lisak RP
Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098
[No Abstract] [Full Text] [Related]
6. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
Neurath MF; Finotto S
Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916
[TBL] [Abstract][Full Text] [Related]
7. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
Hsu MP; Frausto R; Rose-John S; Campbell IL
Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
[TBL] [Abstract][Full Text] [Related]
8. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 is a direct mediator of T cell migration.
Weissenbach M; Clahsen T; Weber C; Spitzer D; Wirth D; Vestweber D; Heinrich PC; Schaper F
Eur J Immunol; 2004 Oct; 34(10):2895-906. PubMed ID: 15368306
[TBL] [Abstract][Full Text] [Related]
10. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.
Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F
Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M: a pleiotropic cytokine in the central nervous system.
Chen SH; Benveniste EN
Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cytokines of interleukin-6 family in gingival fibroblasts by Toll-like receptor-2].
Xin H; Wang YH; Liu H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):523-7. PubMed ID: 23141724
[TBL] [Abstract][Full Text] [Related]
15. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: a complicated picture of autoimmunity.
McFarland HF; Martin R
Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
[TBL] [Abstract][Full Text] [Related]
18. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E
Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150
[TBL] [Abstract][Full Text] [Related]
19. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
Gyülvészi G; Haak S; Becher B
Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
[TBL] [Abstract][Full Text] [Related]
20. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
